Skip to main content

Defining a Minimal Sequential Infection Model to Mature Mouse Immune Responses

NIAID - National Institute of Allergy and Infectious Diseases

open
OpenLast verified: 2026-07-26

About This Grant

PROJECT SUMMARY Recent studies with ‘dirty’ or microbially experienced mice suggest that one crucial difference between mouse models and humans is the history of infection and microbial exposure. Laboratory mice lack the diversity of microbial exposure experienced by their wild mice counterparts and humans. When SPF mice are exposed to microbes found in wild mice their immune responses change and start to more closely mimic the human immune response, indicating that infections are important for maturing the immune response. Because exposing laboratory mice to wild mice is not feasible for many researchers, new mouse models are needed to bridge the gap between mouse and human immune research. We developed a model of sequential infection, where mice are infected with a series of three viruses and an intestinal parasite starting early in life. We showed that mice with sequential infections have different response to vaccination and have blood transcriptional signatures that more closely mimic wild mice and humans. Therefore, we hypothesize that exposure of laboratory mice to a defined and small number of viral and parasitic infections will be sufficient to recapitulate many aspects of other dirty mouse models. We propose to determine which aspects of the immune response of mice exposed to wild mice are recapitulated by our sequential infected mice. We will also determine the contribution of specific pathogens to the alterations in the mouse immune response and test whether the order of infections changes the outcome of the sequential infection model. The conclusion of these experiments will be a well-defined and simple microbial-experienced model that can be reproduced by other investigators. In addition, we will have defined the contribution of specific mouse pathogens to immune system maturity. These experiments will enhance the translatability of mouse models to human preclinical research.

Grant Summary

Defining a Minimal Sequential Infection Model to Mature Mouse Immune Responses is a NIAID - National Institute of Allergy and Infectious Diseases grant providing up to $457K for university, nonprofit, healthcare org. Applications are due 2028-03-31 (open). Check eligibility and apply with FindGrants.

Not quite the right fit?

Search 9,000+ open grants, or get matches ranked for your organization — free.

Focus Areas

health research

Eligibility

universitynonprofithealthcare org

How to Apply

Funding Range

Up to $457K

Deadline

2028-03-31

Complexity
Medium
  1. 1Confirm your organization is eligible for Defining a Minimal Sequential Infection Model to Mature Mouse Immune Responses from NIAID - National Institute of Allergy and Infectious Diseases, checking organization type, location, and any population or project requirements.
  2. 2Gather the required documents and information, including your organization details, project plan, and budget figures.
  3. 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
  4. 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIAID - National Institute of Allergy and Infectious Diseases before the deadline.
This record is a past award, contract, or funder profile — useful for research, but not an open grant application. Check the original source for current opportunities from this funder.

Don't want to draft it yourself?

We'll draft the complete application against NIAID - National Institute of Allergy and Infectious Diseases's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.

AI Requirement Analysis

Detailed requirements not yet analyzed

Have the NOFO? Paste it below for AI-powered requirement analysis.

0 characters (min 50)

Defining a Minimal Sequential Infection Model to Mature Mouse Immune Responses: Frequently Asked Questions

Who is eligible for the Defining a Minimal Sequential Infection Model to Mature Mouse Immune Responses?

Defining a Minimal Sequential Infection Model to Mature Mouse Immune Responses is offered by NIAID - National Institute of Allergy and Infectious Diseases and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.

How much funding does the Defining a Minimal Sequential Infection Model to Mature Mouse Immune Responses provide?

Defining a Minimal Sequential Infection Model to Mature Mouse Immune Responses provides up to $457K per award from NIAID - National Institute of Allergy and Infectious Diseases. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.

When is the Defining a Minimal Sequential Infection Model to Mature Mouse Immune Responses deadline?

Applications for Defining a Minimal Sequential Infection Model to Mature Mouse Immune Responses are due 2028-03-31 (open). Because deadlines can change, verify the date with the funder, NIAID - National Institute of Allergy and Infectious Diseases, and give yourself enough time to prepare a complete, competitive application before the close date.

How do you apply for the Defining a Minimal Sequential Infection Model to Mature Mouse Immune Responses?

To apply for Defining a Minimal Sequential Infection Model to Mature Mouse Immune Responses, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIAID - National Institute of Allergy and Infectious Diseases.